This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Nov 1;74(11):1296-1298.

doi: 10.1001/jamaneurol.2017.1473.

Demystifying Neurosarcoidosis and Informing Prognosis

Jeffrey M Gelfand¹

Affiliations

PMID: 29052731
DOI: 10.1001/jamaneurol.2017.1473

Comment

Demystifying Neurosarcoidosis and Informing Prognosis

Jeffrey M Gelfand. JAMA Neurol. 2017.

. 2017 Nov 1;74(11):1296-1298.

doi: 10.1001/jamaneurol.2017.1473.

Author

Jeffrey M Gelfand¹

Affiliation

¹ Multiple Sclerosis and Neuroinflammation Center, Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco.

PMID: 29052731
DOI: 10.1001/jamaneurol.2017.1473

No abstract available

PubMed Disclaimer

Comment on

Association of Prognostic Factors and Immunosuppressive Treatment With Long-term Outcomes in Neurosarcoidosis.
Joubert B, Chapelon-Abric C, Biard L, Saadoun D, Demeret S, Dormont D, Resche-Rigon M, Cacoub P. Joubert B, et al. JAMA Neurol. 2017 Nov 1;74(11):1336-1344. doi: 10.1001/jamaneurol.2017.2492. JAMA Neurol. 2017. PMID: 29052709 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information